Cite
HARVARD Citation
Leinonen, M. et al. (2013). SAT0440 The IL-1RA Antagonist Kineret® (Anakinra) Stabilizes Hearing Loss in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS). Annals of the rheumatic diseases. pp. A730-A731. [Online].